Locally-administered intrathecal thrombolytics following aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis
- PMID: 20740327
- DOI: 10.1007/s12028-010-9429-z
Locally-administered intrathecal thrombolytics following aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis
Abstract
Background: The volume and clearance rate of blood in the basal cisterns and ventricles are important predictors of complications following aneurysmal subarachnoid hemorrhage (SAH). Thus, there is a strong rationale for interventions aimed at accelerating the clearance of blood.
Methods: We systematically searched MEDLINE, EMBASE, Cochrane databases, references of review articles and gray literature sources to identify randomized controlled trials (RCTs) assessing the efficacy of locally-administered, intrathecal thrombolytics in patients with SAH. Primary outcomes included the occurrence of poor neurologic recovery and delayed neurologic deficits (DNDs). Secondary outcomes included angiographic vasospasm, chronic hydrocephalus and treatment-related complications. Data were extracted and appraised independently and in duplicate, using standardized forms. Fixed or random effects models, as appropriate based on the degree of study heterogeneity were applied to calculate summary measures.
Results: Five RCTs, enrolling 465 patients, met eligibility criteria. The methodology, results and risk of bias varied considerably across individual studies. Overall, use of intrathecal thrombolytics was associated with significant reductions in the development of poor outcomes (OR 0.52, 0.34-0.78, P < 0.01), DNDs (OR 0.54, 0.34-0.87, P = 0.01), angiographic vasospasm (OR 0.32, 0.15-0.70, P < 0.01) and chronic hydrocephalus (OR 0.33, 0.15-0.74, P < 0.01), without any increment in hemorrhagic or infectious complications. These findings were dampened by the exclusion of a study which concomitantly administered intrathecal vasodilators and thrombolytics.
Conclusions: Current data suggests that intrathecal thrombolytics improve outcomes following SAH. However, there are important limitations to existing RCTs, with considerable risk of bias. Further standardization of techniques and evaluation in larger, more rigorous RCTs is required.
Similar articles
-
Intraoperative mild hypothermia for postoperative neurological deficits in people with intracranial aneurysm.Cochrane Database Syst Rev. 2016 Mar 22;3(3):CD008445. doi: 10.1002/14651858.CD008445.pub3. Cochrane Database Syst Rev. 2016. PMID: 27000210 Free PMC article.
-
Intraoperative mild hypothermia for postoperative neurological deficits in intracranial aneurysm patients.Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008445. doi: 10.1002/14651858.CD008445.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2016 Mar 22;3:CD008445. doi: 10.1002/14651858.CD008445.pub3. PMID: 22336843 Updated.
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
-
Endothelin receptor antagonists for subarachnoid hemorrhage.Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD008354. doi: 10.1002/14651858.CD008354.pub2. Cochrane Database Syst Rev. 2012. PMID: 22972119 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
Cited by
-
Current management of delayed cerebral ischemia: update from results of recent clinical trials.Transl Stroke Res. 2014 Apr;5(2):207-26. doi: 10.1007/s12975-013-0316-8. Epub 2013 Dec 13. Transl Stroke Res. 2014. PMID: 24338266 Review.
-
Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial.Neurocrit Care. 2014 Oct;21(2):275-84. doi: 10.1007/s12028-014-9965-z. Neurocrit Care. 2014. PMID: 24627207 Clinical Trial.
-
Vasospasm in cerebral inflammation.Int J Inflam. 2014;2014:509707. doi: 10.1155/2014/509707. Epub 2014 Dec 29. Int J Inflam. 2014. PMID: 25610703 Free PMC article. Review.
-
Advances in the understanding of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage.F1000Res. 2015 Nov 2;4:F1000 Faculty Rev-1200. doi: 10.12688/f1000research.6635.1. eCollection 2015. F1000Res. 2015. PMID: 26937276 Free PMC article. Review.
-
The evidence for a role of vasospasm in the pathogenesis of cerebral malaria.Malar J. 2015 Oct 13;14:405. doi: 10.1186/s12936-015-0928-4. Malar J. 2015. PMID: 26463364 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous